BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 08/01/20

Written by Nick Ackerman, co-produced by Stanford Chemist Recently, we took a position in BlackRock Science & Technology Trust II ( BSTZ ). This was in our Tactical Income-100 Portfolio. This portfolio is designed to be more aggressive and take advantage of special situations. In t...

I could probably go on and on about why the BlackRock Science & Technology II fund ( BSTZ ) , $23.95 current market price, $27.34 NAV, -12.4% discount, 5.0% current market yield , is still a big fat opportunity even after writing this article, Equity CEFs: A Big Fat Opportunity In...

Written by Nick Ackerman, co-produced by Stanford Chemist The first half of 2020 had come in with a bang, and the market quickly hit all-time highs on February 19th. This was even as COVID-19 was beginning to spread around the globe. After reaching those all-time highs, the market quickl...

Written by Nick Ackerman, co-produced by Stanford Chemist Continuing with our coverage of BlackRock funds, as we had done with Eaton Vance's funds, we will be focusing on BlackRock's sector-focused funds. In today's piece, we will be looking at the healthcare and tech names offered by Bl...

Are you looking for exposure to mid- and small-cap tech stocks, but you don't have the time or expertise to research them? And you want to earn some income from the notoriously tight-fisted tech sector? Like its sister fund, BlackRock Science and Technology Trust ( BST ), which we covered ...

(This report was published to members of Yield Hunting on May 15. All data is from that date unless otherwise stated.) AllianzGI Artificial Intelligence & Technology Opportunities Fund ( AIO ) This is a relatively new fund - now seven months old - with Allianz pushing the marketing...

Photo Source: REUTERS/Brendan McDermid. Workers celebrate the during closing bell, as they prepare for the return to trading, on the floor at the New York Stock Exchange ((NYSE)) in New York, U.S., May 22, 2020. For the month, 93% of all closed-end funds (CEFs) posted net-asset-value ((NAV...

Written by Nick Ackerman, co-produced by Stanford Chemist COVID-19 certainly has done much harm to the economy as we start to see the economic data come in. The U.S. GDP sank 4.8% in the first quarter. This certainly comes at no surprise with much of the economy on lockdown. It certain...

The BlackRock Science & Technology II fund ( BSTZ ) , $19.43 current market price, $21.92 NAV, -11.4% discount, 6.2% current market yield , has only been around since last summer when it went public at $20 a share (both market and NAV prices) and already the fund's NAV has risen to ...

Written by Nick Ackerman, co-produced by Stanford Chemist BlackRock launched its fund the BlackRock Health Sciences Trust II ( BMEZ ) on January 29th, 2020. Roughly a month before the broader market had hit all-time highs and the COVID-19 crisis-induced selloff began. In hindsight, this ...